"Aminocaproic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
| Descriptor ID |
D015119
|
| MeSH Number(s) |
D02.241.081.193.150.075 D12.125.213.075
|
| Concept/Terms |
Aminocaproic Acid- Aminocaproic Acid
- 6-Aminohexanoic Acid
- 6 Aminohexanoic Acid
- epsilon-Aminocaproic Acid
- epsilon Aminocaproic Acid
- 6-Aminocaproic Acid
- 6 Aminocaproic Acid
|
Below are MeSH descriptors whose meaning is more general than "Aminocaproic Acid".
Below are MeSH descriptors whose meaning is more specific than "Aminocaproic Acid".
This graph shows the total number of publications written about "Aminocaproic Acid" by people in this website by year, and whether "Aminocaproic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aminocaproic Acid" by people in Profiles.
-
In response: Approaching risk assessment with caution: Epsilon aminocaproic acid and acute kidney injury in the secondary analysis. Transfusion. 2023 Nov; 63(11):2197-2198.
-
A Pharmacokinetic and Pharmacodynamic Investigation of an e-Aminocaproic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. 2021 Feb; 35(2):406-417.
-
Long-term Complications and Management of Gastrointestinal Bleeding in Multifocal Lymphangioendotheliomatosis. J Pediatr Hematol Oncol. 2019 Nov; 41(8):e534-e537.
-
Perioperative Coagulation Management of a Hemophilia A Patient During Cardiac Surgery. Semin Cardiothorac Vasc Anesth. 2017 Dec; 21(4):312-320.
-
A phase III, multicenter, randomized, placebo-controlled clinical trial of topical aminocaproic acid (Caprogel) in the management of traumatic hyphema. Ophthalmology. 2003 Nov; 110(11):2106-12.